Intrauterine growth restriction may reduce hepatic drug metabolism in the early neonatal period
Sign Up to like & getrecommendations! Published in 2018 at "Pharmacological Research"
DOI: 10.1016/j.phrs.2018.06.003
Abstract: Graphical abstract Figure. No caption available. &NA; The effects of intrauterine growth restriction (IUGR) extend well into postnatal life. IUGR is associated with an increased risk of adverse health outcomes, which often leads to greater… read more here.
Keywords: drug; intrauterine growth; iugr; hepatic drug ... See more keywords
Butyrate Treatment of DSS-Induced Ulcerative Colitis Affects the Hepatic Drug Metabolism in Mice
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.936013
Abstract: The development of inflammatory bowel disease (IBD) is associated with alterations in the gut microbiota. There is currently no universal treatment for this disease, thus emphasizing the importance of developing innovative therapeutic approaches. Gut microbiome-derived… read more here.
Keywords: hepatic drug; dss; drug metabolism; colitis ... See more keywords